Fundz
Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

Mineralys Therapeutics Appoints Dr. Terry Ferguson As Chief Medical Officer

PRIVATEAug 11, 2026•about 3 hours ago

Position

Chief Medical Officer

Company

Mineralys Therapeutics

Dr. Terry Ferguson
PhiladelphiaHealth Care

Description

Mineralys Therapeutics has appointed Dr. Terry Ferguson as Chief Medical Officer, effective August 10, 2026, to lead its medical and late-stage clinical activities. The company is advancing toward the commercial launch of lorundrostat, with a PDUFA target date set for December 22, 2026.

Company Information

Company

Mineralys Therapeutics

Location

Philadelphia, Pennsylvania, United States

About

Headquartered in Philadelphia, PA, Mineralys Therapeutics, Inc. is a private, clinical-stage biopharmaceutical company, founded by Catalys Pacific, and is committed to developing best-in-class, novel therapy for the treatment of hypertension. The Company is driven to bring a targeted approach to the management of hypertension via the development of MLS-101. MLS-101, licensed from Mitsubishi Tanabe Pharma Corporation, is a highly selective and potent aldosterone synthase inhibitor that is being investigated for the treatment of hypertension. For more information, please visit https://mineralystx.com/.

Predictive Intelligence
Strategic

ML-powered predictions for Mineralys Therapeutics's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.